Help and Hope for the Glut1 Deficiency Community

Dr. Juan Pascual, Glut1 Deficiency specialist and researcher at the University of Texas Southwestern in Dallas, has announced plans for further clinical studies on the use of triheptanoin (C7) in Glut1 Deficiency patients.  These studies address new questions and will be carried out as part of a grant from the National Institute of Neurological Disorders and Stroke (National Institutes of Health) and the Glut1 Deficiency Foundation. Please visit the link below for additional information and contact details for those interested in participating in the study.

Triheptanoin studies at UTSW